Sara Brilha

Sara Brilha serves as the Associate Director of Global Regulatory Affairs Strategy at Genmab since January 2025. Previously, Sara held various roles at Adaptimmune from April 2017 to January 2025, including Associate Director and Manager of Global Regulatory Affairs, along with positions in regulatory affairs and preclinical writing. Sara's academic background includes a PhD in Clinical Medicine Research obtained from Imperial College London (2011-2015), an MSc in Emerging Infectious Diseases from the University of Lisbon (2009-2011), and a BSc in Microbiology from the University of Lisbon (2004-2009). Additionally, Sara enhanced professional skills through the Regulatory Affairs Professional Society (RAPS) from 2018 to 2019.